64Cu-DOTA-AE105
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 64Cu-DOTA-AE105, covering 2014-12-12 to 2014-12-12. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of a New Radiotracer (64Cu-DOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography [EARLY_Phase 1]